Navidea Biopharmaceuticals Inc (NYSE American:NAVB)

0.24
Delayed Data
As of May 18
 +0.005 / +2.13%
Today’s Change
0.21
Today|||52-Week Range
0.68
-33.05%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
AssetsCash5.5M7.2M6.5M2.8M
 
 
 
 
 
Short Term Investment Cash-27.5M1.7M-625.7K-3.7M
 
 
 
 
 
Cash & Short Term Investments5.5M7.2M6.5M4.6M
 
 
 
 
 
 
ReceivablesReceivables816.5K3.7M1.8M8.1M
 
 
 
 
 
 
InventoriesInventories932.4K652.9K1.5M0.00
 
 
 
 
 
Current AssetsOther Current Assets1.4M1.1M1.0M1.1M
 
 
 
 
 
Current Assets8.6M12.6M10.8M13.8M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross4.1M3.9M3.6M1.2M
 
 
 
 
 
Depreciation-1.6M-1.9M-2.3M-969.4K
 
 
 
 
 
Intangible Assets180.8K186.2K181.0K458.2K
 
 
 
 
 
Other Assets569.8K459.7K383.8K1.9M
 
 
 
 
 
Total Assets11.9M15.0M12.5M20.8M
 
 
 
 
 
 
LiabilitiesAccounts Payable1.5M1.8M7.1M855.0K
 
 
 
 
 
Short Term Debt4.4M333.3K52.0M2.4M
 
 
 
 
 
Accrued Expenses2.0M2.2M1.8M923.1K
 
 
 
 
 
Other Current Liabilities2.3M3.2M9.8M3.9M
 
 
 
 
 
Other Liabilities9.1M6.2M69.9M8.1M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt29.5M60.7M9.6M0.00
 
 
 
 
Other Liabilities3.1M1.7M598.9K664.7K
 
 
 
 
 
Total Liabilities41.7M68.8M80.1M8.7M
 
 
 
 
 
 
EquityMinority Interest0.00-855.00-648.00-210.00
 
 
 
 
Preferred Stock4.000.000.000.00
 
 
Common Equity-29.8M-54.3M-68.1M11.4M
 
 
 
 
 
Total Shareholder Equity-29.8M-54.3M-68.1M11.4M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding150.2M155.6M155.8M162.2M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.